CMS Open Payments · Program Year 2024
Bionova Medical Inc
Bionova Medical Inc reported $1,066,681.00 in payments to 0 physicians and teaching hospitals across 3 transactions.
- $1.1M
- Total payments
- 3
- Transactions
- 0
- Recipients
- #609
- of 1,925 companies
Bionova Medical Inc reported $1,066,681.00 in payments to 0 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #609 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $0.00 per recipient across 0 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
The verdict
Bionova Medical Inc posts above-median payment volume among 1,925 companies reporting payments in CMS Open Payments PY2024.
- #609
- of 1,925 companies
- 0.0%
- of all US industry payments
- 0
- payment categories
How Bionova Medical Inc ranks nationally
Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.
Bionova Medical Inc's total vs. every reporting company
CMS Open Payments, Program Year 2024
$1,066,681 Top 32% higher than 68% of 1,925 reporting companies
Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Open Payments · 2024
What the Data Shows for Bionova Medical Inc
In Program Year 2024, Bionova Medical Inc reported $1,066,681.00 in payments to 0 physicians and teaching hospitals across 3 individual transactions, an average of $355.6K per transaction and $0.00 per recipient. That total places Bionova Medical Inc at rank #609 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.
Payment Size Analysis
Average transaction size: $355.6K. Average per recipient: $0.00.
Total Amount
$1,066,681.00
Avg per Transaction
$355.6K
Avg per Recipient
$0.00
Payment Transparency Context
What is the Sunshine Act?
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.9B
across 1,925 companies
Bionova Medical Inc Share
0.0%
#609 by total payments
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to Bionova Medical Inc
Frequently Asked Questions
How much did Bionova Medical Inc pay to physicians and hospitals in 2024? ▾
How many physicians received payments from Bionova Medical Inc? ▾
What types of payments did Bionova Medical Inc make? ▾
How does Bionova Medical Inc rank among pharmaceutical companies? ▾
What is the average payment size from Bionova Medical Inc? ▾
Where does the payment data for Bionova Medical Inc come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.